Literature DB >> 19157572

Elevated immune response in the brain of autistic patients.

Xiaohong Li1, Abha Chauhan, Ashfaq M Sheikh, Sangita Patil, Ved Chauhan, Xiu-Min Li, Lina Ji, Ted Brown, Mazhar Malik.   

Abstract

UNLABELLED: This study determined immune activities in the brain of ASD patients and matched normal subjects by examining cytokines in the brain tissue. Our results showed that proinflammatory cytokines (TNF-alpha, IL-6 and GM-CSF), Th1 cytokine (IFN-gamma) and chemokine (IL-8) were significantly increased in the brains of ASD patients compared with the controls. However the Th2 cytokines (IL-4, IL-5 and IL-10) showed no significant difference. The Th1/Th2 ratio was also significantly increased in ASD patients.
CONCLUSION: ASD patients displayed an increased innate and adaptive immune response through the Th1 pathway, suggesting that localized brain inflammation and autoimmune disorder may be involved in the pathogenesis of ASD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19157572      PMCID: PMC2770268          DOI: 10.1016/j.jneuroim.2008.12.002

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  24 in total

Review 1.  Genetics of autism: complex aetiology for a heterogeneous disorder.

Authors:  S E Folstein; B Rosen-Sheidley
Journal:  Nat Rev Genet       Date:  2001-12       Impact factor: 53.242

2.  Multiplex bead array assays for detection of soluble cytokines: comparisons of sensitivity and quantitative values among kits from multiple manufacturers.

Authors:  Sameena S Khan; Meghan S Smith; Debra Reda; Anthony F Suffredini; J Philip McCoy
Journal:  Cytometry B Clin Cytom       Date:  2004-09       Impact factor: 3.058

3.  Thrombin and inflammatory proteins are elevated in Alzheimer's disease microvessels: implications for disease pathogenesis.

Authors:  Paula Grammas; Pezhman Ghatreh Samany; Lakshmi Thirumangalakudi
Journal:  J Alzheimers Dis       Date:  2006-03       Impact factor: 4.472

4.  Activation of the inflammatory response system in autism.

Authors:  Jan Croonenberghs; Eugene Bosmans; Dirk Deboutte; Gunter Kenis; Michael Maes
Journal:  Neuropsychobiology       Date:  2002       Impact factor: 2.328

Review 5.  Chemokines and Alzheimer's disease.

Authors:  W J Streit; J R Conde; J K Harrison
Journal:  Neurobiol Aging       Date:  2001 Nov-Dec       Impact factor: 4.673

Review 6.  Interleukin-10 and the interleukin-10 receptor.

Authors:  K W Moore; R de Waal Malefyt; R L Coffman; A O'Garra
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

7.  Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression.

Authors:  H Jyonouchi; S Sun; H Le
Journal:  J Neuroimmunol       Date:  2001-11-01       Impact factor: 3.478

8.  Prevalence of autism in a United States population: the Brick Township, New Jersey, investigation.

Authors:  J Bertrand; A Mars; C Boyle; F Bove; M Yeargin-Allsopp; P Decoufle
Journal:  Pediatrics       Date:  2001-11       Impact factor: 7.124

9.  Innate immunity associated with inflammatory responses and cytokine production against common dietary proteins in patients with autism spectrum disorder.

Authors:  Harumi Jyonouchi; Sining Sun; Nanae Itokazu
Journal:  Neuropsychobiology       Date:  2002       Impact factor: 2.328

10.  Relationship of interleukin-12 and interleukin-13 imbalance with class-specific rheumatoid factors and anticardiolipin antibodies in systemic lupus erythematosus.

Authors:  A Spadaro; R Scrivo; M Bombardieri; V Riccieri; T Rinaldi; E Taccari; G Valesini
Journal:  Clin Rheumatol       Date:  2003-05       Impact factor: 2.980

View more
  247 in total

Review 1.  Maternal immune activation and autism spectrum disorder: interleukin-6 signaling as a key mechanistic pathway.

Authors:  E Carla Parker-Athill; Jun Tan
Journal:  Neurosignals       Date:  2010-10-02

2.  Risperidone-related improvement of irritability in children with autism is not associated with changes in serum of epidermal growth factor and interleukin-13.

Authors:  Zuzana Tobiasova; Klaas H B van der Lingen; Lawrence Scahill; James F Leckman; Yan Zhang; Wookjin Chae; James T McCracken; Christopher J McDougle; Benedetto Vitiello; Elaine Tierney; Michael G Aman; L Eugene Arnold; Liliya Katsovich; Pieter J Hoekstra; Fred Volkmar; Alfred L M Bothwell; Ivana Kawikova
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-11-09       Impact factor: 2.576

3.  Microglia in the cerebral cortex in autism.

Authors:  Nicole A Tetreault; Atiya Y Hakeem; Sue Jiang; Brian A Williams; Elizabeth Allman; Barbara J Wold; John M Allman
Journal:  J Autism Dev Disord       Date:  2012-12

4.  Integrative gene network analysis provides novel regulatory relationships, genetic contributions and susceptible targets in autism spectrum disorders.

Authors:  Tin-Lap Lee; Margarita J Raygada; Owen M Rennert
Journal:  Gene       Date:  2012-01-26       Impact factor: 3.688

Review 5.  Developmental neurotoxicity of inhaled ambient ultrafine particle air pollution: Parallels with neuropathological and behavioral features of autism and other neurodevelopmental disorders.

Authors:  J L Allen; G Oberdorster; K Morris-Schaffer; C Wong; C Klocke; M Sobolewski; K Conrad; M Mayer-Proschel; D A Cory-Slechta
Journal:  Neurotoxicology       Date:  2015-12-22       Impact factor: 4.294

Review 6.  Beyond the brain: A multi-system inflammatory subtype of autism spectrum disorder.

Authors:  Robyn P Thom; Christopher J Keary; Michelle L Palumbo; Caitlin T Ravichandran; Jennifer E Mullett; Eric P Hazen; Ann M Neumeyer; Christopher J McDougle
Journal:  Psychopharmacology (Berl)       Date:  2019-05-28       Impact factor: 4.530

7.  Brief Report: Antibodies Reacting to Brain Tissue in Basque Spanish Children with Autism Spectrum Disorder and Their Mothers.

Authors:  Christy C Rossi; Joaquin Fuentes; Judy Van de Water; David G Amaral
Journal:  J Autism Dev Disord       Date:  2013-09-11

8.  Altered mRNA Levels of Glucocorticoid Receptor, Mineralocorticoid Receptor, and Co-Chaperones (FKBP5 and PTGES3) in the Middle Frontal Gyrus of Autism Spectrum Disorder Subjects.

Authors:  Neil Patel; Amanda Crider; Chirayu D Pandya; Anthony O Ahmed; Anilkumar Pillai
Journal:  Mol Neurobiol       Date:  2015-04-26       Impact factor: 5.590

9.  Resveratrol Ameliorates Dysregulation of Th1, Th2, Th17, and T Regulatory Cell-Related Transcription Factor Signaling in a BTBR T + tf/J Mouse Model of Autism.

Authors:  Saleh A Bakheet; Mohammad Zeed Alzahrani; Mushtaq Ahmad Ansari; Ahmed Nadeem; Khairy M A Zoheir; Sabry M Attia; Laila Yousef Al-Ayadhi; Sheikh Fayaz Ahmad
Journal:  Mol Neurobiol       Date:  2016-08-30       Impact factor: 5.590

10.  Neurotensin stimulates sortilin and mTOR in human microglia inhibitable by methoxyluteolin, a potential therapeutic target for autism.

Authors:  Arti B Patel; Irene Tsilioni; Susan E Leeman; Theoharis C Theoharides
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-23       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.